top of page

The Brain, Mind, and Ethics of Psychedelics - Q and A

A fascinating Q&A on the ethical and philosophical considerations in psychedelic science and explanations of the psychedelic experience. Prof David Nutt David is a leading Neuroscientist and drug policy reform advocate. Formerly the Chief Drug Advisor to the UK government he is currently the Edmond J. Safra Professor of Neuropsychopharmacology and director of the unit in the Division of Brain Sciences at Imperial College London. He has published over 400 original research papers, 8 government reports on Drugs and 28 books. He is currently the President of the European Brain Council and Founding Chair of Drug Science Eddie Jacobs Eddie is based at the University of Oxford, where he is a research fellow at the Wellcome Centre for Ethics and Humanities, and a PhD student at the Department of Psychiatry. He focuses on some of the ethical dimensions of bringing psychedelic-assisted therapy into the fold as part of our approach to treating mental health conditions, and the need to recognise that the psychedelic journey doesn’t stop after your integration sessions. Dr Peter Sjöstedt-Hughes Peter is an Anglo-Scandinavian philosopher of mind who specializes in the thought of Whitehead and Nietzsche, and in fields pertaining to panpsychism and altered states of sentience. He has been called ‘a psychedelic Nietzsche’. This webinar was recorded during a Drug Science Live Event which included a live Q&A session from the audience. If you want to ensure that you don’t miss any of our events, so that you can ask your questions live, all you need to do is join the Drug Science Mailing List. Drug Science is the leading independent scientific body on drugs in the UK. We rely on donations to provide clear, evidence-based information without political or commercial interference. Drug Science webinars are free, and always will be, so if you’d like to support us then please consider joining the Drug Science Community

Keep up with developments in drug science

Reading, engaging with, and sharing our publications, papers and commentary gives evidence-based science and policy the audience it needs and deserves.

bottom of page